Terumo BCT
Susanne Marschner has not added Biography.
If you are Susanne Marschner and would like to personalize this page please email our Author Liaison for assistance.
Ligation of human CD4 interferes with antigen-induced activation of primary T cells.
Immunology letters Jun, 2002 | Pubmed ID: 12008044
CXCR4 engagement is required for HIV-1-induced L-selectin shedding.
Blood Feb, 2004 | Pubmed ID: 14576059
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
Cancer research Oct, 2007 | Pubmed ID: 17942927
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.
Transplantation Nov, 2007 | Pubmed ID: 17998874
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.
Transfusion Dec, 2009 | Pubmed ID: 19682337
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
Transfusion Dec, 2009 | Pubmed ID: 19694996
White blood cell inactivation after treatment with riboflavin and ultraviolet light.
Transfusion Nov, 2010 | Pubmed ID: 20529002
The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.
Blood transfusion = Trasfusione del sangue Jul, 2010 | Pubmed ID: 20671879
Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie , 2009 | Pubmed ID: 21076549
Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.
Transfusion Jun, 2011 | Pubmed ID: 21155831
Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation.
Transfusion Jul, 2011 | Pubmed ID: 21155832
In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.
Transfusion Jul, 2011 | Pubmed ID: 21275998
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie , 2011 | Pubmed ID: 21779202
In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
Transfusion May, 2012 | Pubmed ID: 22014032
The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
Immunology letters Mar, 2012 | Pubmed ID: 22370159
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Transfusion Feb, 2013 | Pubmed ID: 22612327
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
Transfusion Jan, 2013 | Pubmed ID: 23301965
Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.
Transfusion Mar, 2013 | Pubmed ID: 23451715
Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
Journal of clinical apheresis Feb, 2015 | Pubmed ID: 24941931
Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Transfusion Dec, 2014 | Pubmed ID: 25438832
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
Transfusion Jul, 2015 | Pubmed ID: 25702711
Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
Transfusion Jul, 2015 | Pubmed ID: 25731607
Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice.
PloS one , 2015 | Pubmed ID: 26176623
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved